Insider · CIK 0001688712
Dawn Carter Bir
Files at GERN (GERON CORP), FLNA (CASSAVA SCIENCES INC), SLNO (SOLENO THERAPEUTICS INC). First filing -, latest -.
In brief
Dawn Carter Bir files SEC Form 4 as CEO, president and director at GERN (GERON CORP), and also at FLNA (CASSAVA SCIENCES INC), SLNO (SOLENO THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dawn Carter Bir has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | GERN GERON CORP | AGrant or award Stock Option (right to buy)derivative | +220,000 | $0.00 | $0 | 220,000 | May 26, 2026 |
| May 18, 2026 | SLNO SOLENO THERAPEUTICS INC | DDisposition to issuer Common Stock | -16,991 | - | - | 0 | May 18, 2026 |
| Oct 21, 2025 | FLNA CASSAVA SCIENCES INC | AGrant or award Stock Option (Right to Buy)derivative | +53,000 | $0.00 | $0 | 53,000 | Oct 22, 2025 |
| Jun 5, 2025 | SLNO SOLENO THERAPEUTICS INC | AGrant or award Common Stock | +3,991 | $0.00 | $0 | 16,991 | Jun 9, 2025 |
| May 21, 2025 | GERN GERON CORP | AGrant or award Stock Option (right to buy)derivative | +180,000 | $0.00 | $0 | 180,000 | May 22, 2025 |
Questions about Dawn Carter Bir
Answered from the filings on this page, as of the latest one.
Is Dawn Carter Bir buying or selling?
Dawn Carter Bir has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dawn Carter Bir's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dawn Carter Bir has 0.
Where does Dawn Carter Bir file Form 4?
Dawn Carter Bir has filed Form 4 at GERN (GERON CORP) as Interim President and CEO; FLNA (CASSAVA SCIENCES INC); SLNO (SOLENO THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.